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A B S T R A C T
Background
Immediate delivery of the preterm fetus with suspected compromise may decrease the risk of damage due to intrauterine hypoxia.
However, it may also increase the risks of prematurity.
Objectives
To assess the effects of immediate versus deferred delivery of preterm babies with suspected fetal compromise on neonatal, maternal
and long-term outcomes.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (27 February 2012).
Selection criteria
Randomised trials comparing a policy of immediate delivery with deferred delivery or expectant management in preterm fetuses with
suspected in utero compromise. Quasi-randomised trials and trials employing a cluster-randomised design were eligible for inclusion
but none were identified.
Data collection and analysis
Two review authors independently evaluated trials for inclusion into the review. Two review authors assessed trial quality and extracted
data. Data were checked for accuracy.
Main results
We included one trial of 548 women (588 babies) in the review. There was no difference in the primary outcomes of extended perinatal
mortality (risk ratio (RR) 1.17, 95% confidence interval (CI) 0.67 to 2.04) or the composite outcome of death or disability at or after
two years (RR 1.22, 95% CI 0.85 to 1.75) with immediate delivery compared to deferred delivery. More babies in the immediate
delivery group were ventilated for more than 24 hours (RR 1.54, 95% CI 1.20 to 1.97). There were no differences between the
immediate delivery and deferred delivery groups in any other individual neonatal morbidity or markers of neonatal morbidity (cord
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pH less than 7.00, Apgar less than seven at five minutes, convulsions, interventricular haemorrhage or germinal matrix haemorrhage,
necrotising enterocolitis and periventricular leucomalacia or ventriculomegaly).
More children in the immediate delivery group had cerebral palsy at or after two years of age (RR 5.88, 95% CI 1.33 to 26.02). There
were, however, no differences in neurodevelopment impairment at or after two years (RR 1.72, 95% CI 0.86 to 3.41) or death or
disability in childhood (six to 13 years of age) (RR 0.82, 95% CI 0.48 to 1.40). More women in the immediate delivery group had
caesarean delivery than in the deferred delivery group (RR 1.15, 95% CI 1.07 to 1.24). Data were not available on any other maternal
outcomes.
Authors’ conclusions
Currently there is insufficient evidence on the benefits and harms of immediate delivery compared with deferred delivery in cases of
suspected fetal compromise at preterm gestations to make firm recommendations to guide clinical practice. Where there is uncertainty
whether or not to deliver a preterm fetus with suspected fetal compromise, there seems to be no benefit to immediate delivery. Deferring
delivery until test results worsen or increasing gestation favours delivery may improve the outcomes for mother and baby. More research
is needed to guide clinical practice.
P L A I N L A N G U A G E S U M M A R Y
Immediate or deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
When there is concern that a baby in the womb may not be receiving enough oxygen or nutrients, the choice is to deliver the baby
immediately following a course of steroids to help the baby’s lungs to mature or to wait as long as is thought to be safe. Waiting allows
the baby to develop as much as possible and decreases the risks associated with prematurity. Immaturity of the newborn can lead to
respiratory distress, hypothermia (reduced body temperature), low blood sugar levels, infection and jaundice. Remaining in the womb
may mean the baby experiences damage of vital organs from the lack of oxygen. The aim of this review was to assess which management
option was better for mothers and babies.
We included one randomised study that involved 548 pregnant women (and 588 babies) with pregnancies between 24 and 36 weeks’
gestation. The study was performed in 13 countries, between 1993 and 2001. Women were included if their doctor was concerned
about the developing baby but unsure if immediate delivery was indicated. The women were randomly allocated to immediate delivery
or delivery when the doctor considered that it was necessary.
For preterm babies with suspected fetal compromise and uncertainty about whether to deliver or not, there appears to be no benefit
to immediate delivery. There was no difference in death or disability at two years of age between the groups. More women in the
immediate delivery group were delivered by caesarean section and more babies delivered immediately required mechanical ventilation
for longer than 24 hours. The number of infants with cerebral palsy at two years of age was also higher in the immediate delivery group
but there was no differences in neurodevelopment impairment at or after two years, or death or disability in childhood (six to 13 years
of age). Deferred delivery may be preferable, but further studies need to be performed to confirm these findings ant to determine any
differences neonatal deaths. The difference in the median time between randomisation and delivery in the two groups was four days.
B A C K G R O U N D
Description of the condition
Fetal compromise occurs when there is an inadequate oxygen or
nutrient supply to the developing baby. This can be recognised
by progressive alterations in the growth, metabolic, cardiovascular
and behavioural parameters of the fetus, which represent increas-
ing hypoxaemia and acidosis. The function of vital organs may be
affected, leading to temporary or permanent damage or intrauter-
ine death. Fetal compromise is most commonly a result of placen-
tal insufficiency, which occurs in approximately 3% of pregnan-
cies (Alberry 2007). This is thought to originate from defective
trophoblast invasion in the first trimester (Miller 2008), leading
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to increased placental vascular resistance that impairs oxygen and
nutrient supply to the fetus. Other causes include congenital ab-
normality, isoimmunisation, intrauterine infection and twin-twin
transfusion syndrome in monochorionic twins. The degree and
progression of fetal compromise is variable, and is probably de-
pendent on gestation, maternal factors and the nature and severity
of the underlying cause (Miller 2008).
A number of interventions have been proposed as in utero treat-
ments for fetal compromise, including calcium channel blockers,
hormones, steroids, nutritional supplementation, oxygen therapy,
plasma volume expansion, abdominal decompression, electrostim-
ulation, betamimetics and bed rest. Many of these have been re-
viewed in other Cochrane Reviews and none have been found to
be effective in improving outcome (Hofmeyr 1996; Say 1996a;
Say 1996b; Say 1996c; Say 1996d; Say 2001; Say 2003a; Say
2003b; Say 2003c). An exception is in cases of compromise due
to twin-twin transfusion syndrome. This is a distinct condition
where compromise arises due to vascular anastomoses in the pla-
cental circulation of monochorionic twins. In this situation there
is some evidence that laser coagulation of anastomotic vessels im-
proves perinatal outcome (Roberts 2008), hence we have excluded
this group from this review. In all other situations leading to fetal
compromise, in the absence of effective interventions, the main-
stay of management is based on monitoring progression of fetal
compromise and delivering the baby at a time that is thought to
minimise risk to the infant.
Deciding the optimal timing for delivery of preterm babies with
fetal compromise is often difficult. Immediate delivery removes
the baby from the hostile uterine environment, decreasing the risk
of damage due to hypoxia. However, these benefits must be offset
against the risks of increased morbidity and mortality associated
with premature delivery. The earlier the gestation at delivery, the
greater the risk to the baby of developing complications (Iacovidou
2010). Immaturity of neonatal homeostatic mechanisms predis-
pose preterm babies to respiratory distress, hypothermia, hypogly-
caemia, infection and jaundice. The incidence of serious morbidi-
ties increases as gestation decreases, including chronic lung dis-
ease, necrotising enterocolitis, retinopathy of prematurity, intra-
ventricular haemorrhage and periventricular leukomalacia, which
all can lead to death or long-term disability. In survivors, there is
also an apparent dose response between gestation at delivery and
cerebral palsy, intellectual impairment and behavioural problems.
The presentation of fetal compromise is variable. Recognition of
the pregnancy at risk of fetal compromise may be based on clin-
ical features, such as obstetric history or the presence of medical
conditions associated with placental insufficiency. Abnormal fetal
growth or liquor production may be found on abdominal palpa-
tion, or on ultrasound examination. A decrease in fetal movements
may be perceived by the mother, or fetal heart rate abnormalities
may be detected on cardiotocograph (CTG).
Several different methods can be used to assess fetal compromise
including the following.
• Serial ultrasound biometry (Bricker 2009), which can
detect reduction in fetal growth velocity. This is often performed
in conjunction with ultrasound assessment of amniotic fluid,
which if reduced may reflect reduction in fetal urine production
secondary to reduced renal blood flow which occurs as a
physiological response to poor placental blood flow.
• Umbilical artery Doppler ultrasound (Alfirevic 2010),
which can detect increased resistance or absent or reversed end-
diastolic flow. This reflects increasing placental vascular
resistance and damage.
• Fetal arterial Doppler ultrasound (e.g. middle cerebral
artery or aortic isthmus) (Alfirevic 2010), which can detect
decreased resistance, indicative of brain sparing.
• Fetal venous Doppler ultrasound (e.g. ductus venosus or
inferior vena cava) (Alfirevic 2010). Abnormalities reflect pre-
terminal impairment of cardiac function.
• CTG (Grivell 2010), which can detect changes in fetal
heart reactivity.
• Computerised CTG (Guzman 1996), which can detect
changes suggestive of fetal hypoxaemia and acidaemia.
• Biophysical profile (Lalor 2008), which consists of CTG in
combination with ultrasound to detect changes in fetal behaviour
and reduction in amniotic fluid volume that can occur secondary
to decreased renal blood flow and fetal urine production. The
combination of CTG and amniotic fluid volume assessment
alone is called the modified biophysical profile.
The diagnosis of fetal compromise, and the uncertainties in its
management can be very distressing for women and their families.
Suspected or proven fetal compromise is likely to increase anxiety
about pregnancy outcome, and the need for intensive monitoring
or admission can be disruptive and result in separation from the
family.
Description of the intervention
Once fetal compromise is recognised, the options are immediate
delivery (with or without awaiting 24 to 48 hours for administra-
tion of antenatal steroids to promote fetal lungmaturity) or expec-
tant management. Expectant management involves monitoring
progression of fetal compromise and, if monitoring is sufficiently
reassuring, either allowing pregnancy to continue to a certain ges-
tational age or the onset of spontaneous labour, or delivering the
fetus when it is thought that the degree of in utero compromise
imminently jeopardises fetal well-being. Fetal monitoring can in-
volve any of the methods described above, and a combination of
methods are often used. Other Cochrane Reviews (Alfirevic 2010;
Grivell 2009; Lalor 2008; Nabhan 2008) focus on methods and
frequency of assessing fetal compromise. Delivery is most often
achieved by caesarean section, although occasionally induction of
labour may be attempted.
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Why it is important to do this review
Despite advances in technology for recognition of fetal compro-
mise, considerable controversy surrounds whether a policy of im-
mediate or deferred delivery provides the best outcome for these
infants. Evidence regarding the risks and benefits of each approach
is needed to direct management decisions for women with sus-
pected fetal compromise.
O B J E C T I V E S
To assess the effects of immediate versus deferred delivery of
preterm babies with suspected fetal compromise on neonatal, ma-
ternal and long-term outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised trials and quasi-randomised trials, including clus-
ter-randomised trials, comparing a policy of immediate delivery
with deferred delivery or expectant management in preterm fe-
tuses with suspected in utero compromise.
Types of participants
Pregnant women at less than 36 weeks’ gestation in whom there
is clinical suspicion of fetal compromise as defined by trialists.
Outcomes of pregnancies with fetal compromise diagnosed after
36 weeks’ gestation are the focus of another Cochrane Review
(Bond 2011).
We includedmultiple pregnancies.We intended to separatemono-
chorionic and dichorionic twins where possible and exclude
women with twin-twin transfusion syndrome. This is because in-
terventions are available that are thought to improve outcome in
twin-twin transfusion, so expectant management is less relevant.
However, this information was not available.
Types of interventions
Immediate delivery or deferred delivery. Immediate delivery may
be by induction of labour or caesarean section. It may or may
not include time for a course of effective antenatal steroids (48
hours). Deferred deliverymay be for a set period of time, until test
resultsworsen, or expectantmanagement (waiting for spontaneous
labour).
Types of outcome measures
Primary outcomes
1. Extended perinatal mortality (intrauterine death or death in
the first 28 days of life).
2. Serious neonatal morbidity (composite outcome including
bronchopulmonary dysplasia (BPD), necrotising enterocolitis
(NEC), intraventricular haemorrhage (IVH), retinopathy of
prematurity (ROP), hypoxic Ischaemic encephalopathy (HIE).
3. Death or disability at or after two years of age.
Secondary outcomes
Perinatal
1. Stillbirth (intrauterine death of fetus at more than 24
weeks’ gestation)
2. Neonatal mortality (death of a baby born with signs of life
within 28 days of birth).
3. Postneonatal mortality (death of a baby greater than 28
days up to one year of life).
Fetal/neonatal
1. Cord pH less than 7.0.
2. Apgar less than seven at five minutes.
3. Apgar less than four at five minutes.
4. Any admission to neonatal intensive care or special care
facility.
5. Any resuscitation required.
6. Intubation/ventilation required.
7. Interval between randomisation and delivery.
8. Gestation less than 28 weeks at delivery.
9. Gestation less than 34 weeks at delivery.
10. Birthweight less than tenth centile.
11. Birthweight less than fifth centile.
12. Birthweight less than third centile.
13. Low birthweight (less than 2.5 kg).
14. Very low birthweight (less than 1.5 kg).
15. Respiratory distress syndrome (as defined by trialists).
16. Meconium aspiration (as defined by trialists).
17. Seizures (as defined by trialists).
18. Infection or sepsis (as defined by trialists).
19. Neonatal cooling performed.
20. Any HIE (grade I, II or III).
21. Moderate or severe HIE (grade II or grade III).
22. IVH or germinal matrix haemorrhage (GMH).
23. BPD.
24. NEC (as defined by trialists).
25. ROP requiring treatment.
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26. Periventricular leucomalacia (PVL) or ventriculomegaly.
27. Length of hospital stay.
Maternal
1. Caesarean section.
2. Induction of labour.
3. Spontaneous vaginal birth.
4. Operative vaginal birth.
5. Breastfeeding.
6. Maternal satisfaction with care.
7. Antenatal admission (days).
8. Any antenatal complication (pre-eclampsia,
thromboembolic disease, antepartum haemorrhage, infection,
other).
9. Administration of antenatal corticosteroids.
Long-term outcomes
1. Neurodevelopmental impairment at or after two years of
age.
2. Cerebral palsy at or after two years of age.
Non-prespecified outcomes
We also reported the following additional outcomes that we con-
sidered to be important. These were not prespecified in our pro-
tocol.
1. Death at or after two years of age.
2. Kaufman-Assessment Battery for Children Mental
Processing Component Score in childhood.
3. Death or severe disability in childhood.
4. Ventilation for more than 24 hours.
Search methods for identification of studies
Electronic searches
We contacted the Trials Search Co-ordinator to search the
Cochrane Pregnancy and Childbirth Group’s Trials Register (27
February 2012).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of EMBASE;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
EMBASE, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
We did not apply any language restrictions.
Data collection and analysis
Selection of studies
Two review authors independently assessed for inclusion all the
potential studies identified as a result of the search strategy. We
resolved discrepancies through discussion or, if required, consulted
a third assessor.
Data extraction and management
We designed a form to extract data. For eligible studies, two re-
view authors extracted the data using the agreed form. We re-
solved discrepancies through discussion or, if required, consulted
a third person. Data were entered into Review Manager software
(RevMan 2011) and checked for accuracy.
When information regarding any of the above was unclear, we
attempted to contact authors of the original reports to provide
further details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for the in-
cluded study using the criteria outlined in theCochrane Handbook
for Systematic Reviews of Interventions (Handbook) (Higgins 2011).
We resolved any disagreement by discussion or by involving a third
assessor.
(1) Sequence generation (checking for possible selection
bias)
We described for the included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk (any truly random process, e.g. random number
table; computer random number generator);
• high risk (any non-random process, e.g. odd or even date of
birth; hospital or clinic record number);
• unclear risk.
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(2) Allocation concealment (checking for possible selection
bias)
We described for the included study the method used to conceal
the allocation sequence in sufficient detail to determine whether
intervention allocation could have been foreseen in advance of, or
during recruitment, or changed after assignment.
We assessed the methods as:
• low risk (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk (open random allocation; unsealed or non-opaque
envelopes, alternation; date of birth);
• unclear risk.
(3) Blinding (checking for possible performance bias)
We described for the included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We judged studies at low risk
of bias if theywere blinded, or if we judged that the lack of blinding
could not have affected the results. We assessed blinding separately
for different outcomes or classes of outcomes.
We have assessed the methods as:
• low risk, high risk or unclear risk for participants or
personnel.
• low risk, high risk or unclear risk for outcome assessors.
(4) Incomplete outcome data (checking for possible attrition
bias through withdrawals, dropouts, protocol deviations)
We described for the included study, and for each outcome or class
of outcomes, the completeness of data including attrition and ex-
clusions from the analysis. We stated whether attrition and exclu-
sions were reported, the numbers included in the analysis at each
stage (compared with the total randomised participants), reasons
for attrition or exclusionwhere reported, andwhethermissing data
were balanced across groups or were related to outcomes. Where
sufficient information was reported, or could be supplied by the
trial authors, we re-included missing data in the analyses which
we undertook. We assessed methods as:
• low risk (less than 5% of participants);
• high risk (5% or more of participants);
• unclear risk.
(5) Selective reporting bias
We described for the included study how we investigated the pos-
sibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk (where it is clear that all of the study’s pre-specified
outcomes and all expected outcomes of interest to the review
have been reported);
• high risk (where not all the study’s pre-specified outcomes
have been reported; one or more reported primary outcomes were
not pre-specified; outcomes of interest are reported incompletely
and so cannot be used; study fails to include results of a key
outcome that would have been expected to have been reported);
• unclear risk.
(6) Other sources of bias
We described for the included study any important concerns we
have about other possible sources of bias.
We assessed whether the included study was free of other problems




(7) Overall risk of bias
We made explicit judgements about whether the included study
was at high risk of bias, according to the criteria given in the
Handbook (Higgins 2011). With reference to (1) to (6) above, we
assessed the likelymagnitude and direction of the bias andwhether
we considered it likely to impact on the findings. We considered
this to be unlikely and therefore have not undertaken sensitivity
analyses - see Sensitivity analysis.
Measures of treatment effect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
For continuous data, we used themean difference.We only identi-
fied one study for inclusion in this review. In future updates of this
review, we will use the standardised mean difference to combine
trials that measure the same outcome, but use different methods.
Unit of analysis issues
Cluster-randomised trials
We did not identify any cluster-randomised trials. However, in
future updates of this review we will include cluster-randomised
trials in the analyses if they are identified, along with individu-
ally-randomised trials. We will adjust their sample sizes using the
methods described in the Handbook using an estimate of the in-
tracluster correlation co-efficient (ICC) derived from the trial (if
possible), or from another source. If ICCs from other sources are
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used, we will report this and conduct sensitivity analyses to inves-
tigate the effect of variation in the ICC. If we identify both cluster-
randomised trials and individually-randomised trials, we plan to
synthesise the relevant information. We will consider it reasonable
to combine the results from both if there is little heterogeneity
between the study designs and the interaction between the effect
of intervention and the choice of randomisation unit is considered
to be unlikely.
We will also acknowledged heterogeneity in the randomisation
unit and perform a separate meta-analysis.
Dealing with missing data
For the included study, we noted levels of attrition. If in future
updates of this review, we identify studies with high levels of miss-
ing data (5% or more of participants), we will explore the impact
of including them in the overall assessment of treatment effect by
using sensitivity analysis.
For all outcomes we have carried out analyses, as far as possible,
on an intention-to-treat basis, i.e. we have attempted to include
all participants randomised to each group in the analyses. The
denominator for each outcome in each trial is the number ran-
domised minus any participants whose outcomes are known to be
missing.
Assessment of heterogeneity
Only one study was identified by our search strategy. However, if
other studies are identified in future updates of this review, we will
assess statistical heterogeneity in each meta-analysis using the T²,
I² and Chi² statistics. We will regard heterogeneity as substantial
if T² is greater than zero and either I² is greater than 30% or there
is a low P value (less than 0.10) in the Chi² test for heterogeneity.
Assessment of reporting biases
In future updates of this review, if there are 10 or more studies
in the meta-analysis, we will investigate reporting biases (such as
publication bias) using funnel plots. We will assess funnel plot
asymmetry visually, anduse formal tests for funnel plot asymmetry.
For continuous outcomes we will use the test proposed by Egger
1997, and for dichotomous outcomeswewill use the test proposed
by Harbord 2006. If we detect asymmetry in any of these tests
or by a visual assessment, we will perform exploratory analyses to
investigate it.
Data synthesis
We carried out statistical analysis using the Review Manager soft-
ware (RevMan 2011). In future updates of this review, we will use
fixed-effectmeta-analysis for combining datawhere it is reasonable
to assume that studies are estimating the same underlying treat-
ment effect: i.e. where trials are examining the same intervention,
and the trials’ populations and methods are judged sufficiently
similar. If there is clinical heterogeneity sufficient to expect that
the underlying treatment effects differ between trials, or if sub-
stantial statistical heterogeneity is detected, we will use random-
effects meta-analysis to produce an overall summary if an average
treatment effect across trials is considered clinically meaningful.
We will treat the random-effects summary as the average range of
possible treatment effects and discuss the clinical implications of
treatment effects differing between trials. If the average treatment
effect is not clinically meaningful, we will not combined trials.
If, in future updates of this review, if we use random-effects analy-
ses, we will present the results as the average treatment effect with
its 95% confidence interval, and the estimates of T² and I².
Subgroup analysis and investigation of heterogeneity
If we identify more than one study in future updates of this re-
view, and there is substantial heterogeneity, we will investigate it
using subgroup analyses and sensitivity analyses. We will consider
whether an overall summary is meaningful, and if it is, use ran-
dom-effects analysis to produce it.
We planned to carry out the following subgroup analyses.
1. Gestation less than 28 weeks, 28 to 31+6 weeks, 32 to 36
weeks.
2. Singleton and multiple pregnancies.
3. Male and female babies.
4. Underlying cause of fetal compromise: placental
insufficiency, congenital abnormality, isoimmunisation,
intrauterine infection.
5. Severity of fetal compromise: positive end diastolic flow in
umbilical artery Doppler, absent or reversed end-diastolic flow in
umbilical artery Doppler, abnormal arterial or venous Doppler.
We planned to use the following outcomes in subgroup analysis.
1. Perinatal mortality.
2. Serious neonatal morbidity (composite outcome including
bronchopulmonary dysplasia (BPD), necrotising enterocolitis
(NEC), intraventricular haemorrhage (IVH), retinopathy of
prematurity (ROP), hypoxic ischaemic encephalopathy (HIE)).
3. Death or disability at or after two years of age.
Data were not available to allow us to perform any of the pre-
specified subgroup analyses, but these will be included in future
updates of the review if other studies are identified. For fixed-ef-
fect inverse variance meta-analyses, we will examine differences
between subgroups by interaction tests. For random-effects and
fixed-effect meta-analyses using methods other than inverse vari-
ance, we will assess differences between subgroups by inspection of
the subgroups’ confidence intervals; non-overlapping confidence
intervals indicate a statistically significant difference in treatment
effect between the subgroups.
In the single study included in this review, data were reported for
the following subgroups.
• Group A. Gestation 24 to 30 weeks.
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• Group B. Gestation 31 to 36 weeks.
As the effect of gestation could be important, we performed post
hoc subgroup analysis for these groups for the following outcome.
1. Death or disability at or after two or more years of age.
Data were not available to allow subgroup analysis of the other
primary outcomes (extended perinatal mortality or serious neona-
tal morbidity).
Sensitivity analysis
In future updates of this review, as more data become available, we
will perform sensitivity analyses to explore the effect of trial quality
on results, if there is a risk of bias associatedwith the quality of some
of the included trials. We will use sensitivity analysis to explore
the effects of fixed-effect or random-effects analyses for outcomes
with statistical heterogeneity and the effects of any assumptions
made such as the value of the ICC used for cluster-randomised
trials.
We will use the following outcomes in sensitivity analysis.
1. Perinatal mortality.
2. Serious neonatal morbidity (composite outcome including
BPD, NEC, IVH, ROP, HIE).
3. Death or disability at or after two years of age.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
See Characteristics of included studies.
Results of the search
The search of the Pregnancy andChildbirthGroup’sTrialsRegister
identified two trials (in six reports). One study has been included
(Thornton 2004) and one excluded (Langenveld 2011).
Included studies
We included one study (Thornton 2004), involving 548 women
(588 babies). The Growth Restriction Intervention Study (GRIT
study), led to five publications (three manuscripts GRIT 2003;
Thornton 2004; Walker 2011, and two abstracts Hornbuckle
1999; Schneider 2000).
Thornton 2004, compared outcomes of immediate delivery and
deferred delivery in fetuses with suspected in utero compromise.
It was a multicentre randomised trial recruiting over a seven-year
period (November 1993 to March 2001), with participants re-
cruited from69hospitals in 13 countries (Belgium,Cyprus, Czech
Republic, Germany, Greece, Hungary, Italy, Netherlands, Poland,
Portugal, Saudi Arabia, Slovenia, United Kingdom). Women were
included if theywere 24 to36weeks’ gestation andhad a pregnancy
with suspected fetal compromise, with the umbilical Doppler
waveform recorded, and clinical uncertainty as to whether the fe-
tus should be immediately delivered or not. Immediate delivery
was defined as delivery within 48 hours to allow completion of a
steroid course to promote fetal lung maturity. Deferred delivery
was when worsening test results or the passage of time favoured
delivery, so safe delivery could be no longer deferred. The degree
of fetal compromise was not specified, but data were collected to
allow investigations of interactions between the degree of compro-
mise and the gestation at randomisation, and outcome.
Women with both singleton (n = 509) and multiple (n = 39) preg-
nancies were included (588 babies). Both groups were compara-
ble at randomisation. The primary outcome was originally “in-
fant survival to hospital discharge and the Griffith’s developmental
quotient (DQ) at two years of age”. However, this was changed to
“death or disability at or after two years of age” which was felt to be
a more precise outcome. Agreement for this change was obtained
during the trial, from the data monitoring and ethics committee.
Disability was defined as cerebral palsy, little or no vision, require-
ment for a hearing aid, or a Griffiths DQ of 70 or less. The pri-
mary outcome was reported in Thornton 2004. An earlier publi-
cation (GRIT 2003), reported early outcomes including mode of
delivery, perinatal mortality and indicators of neonatal morbidity.
A subsequent manuscript reported childhood outcomes (Walker
2011), including Kaufman-Assessment Battery for ChildrenMen-
tal Processing Component (Kaufman ABC MPC) and death or
disability, at six to 13 years, in a subset of the original cohort.
Two abstracts were also published (Hornbuckle 1999; Schneider
2000), but these were interim analysis and so data from these were
not included in this review.
The study analysis and data monitoring were Bayesian. Odds ra-
tios were calculated and used to revise hypothetical prior beliefs
about the outcomes of immediate or deferred delivery. There were
no specified stopping rules for the trial. Interim analyses of un-
masked data were presented to the data monitoring committee
every year and to clinical collaborators every two years. The aim of
this was to allow individuals with strong prior beliefs on the value
of intervention to stop recruiting if they were no longer clinically
uncertain, and to encourage other clinicians to recruit if they be-
came unsure of the benefit of delivery.
Excluded studies
The HYPITAT II trial (Langenveld 2011) is ongoing and is an-
ticipated to complete in 2013. This study investigates immediate
or deferred delivery for maternal indications (gestational hyper-
tension, chronic hypertension or pre-eclampsia) rather than for
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suspected fetal compromise.
Risk of bias in included studies
Allocation
In the included study (Thornton 2004), allocation was performed
by an independent programmer. During office hours, a computer-
generated sequence was used, and out of office hours, a paper-
based number sequence with balanced blocks of eight to 12 was
used, so allocation was masked from participating clinicians.
Blinding
The nature of the intervention meant that blinding of patients
or personnel was not possible. Indeed, unmasked interim analysis
data were presented to collaborators, as part of trial design, as
analysis was planned to be Bayesian with odds ratios obtained used
to revise prior beliefs about outcomes.
Assesors performing assessments at two years were blinded to ran-
domisation group so the risk of detection bias was low for the
primary outcome.
Incomplete outcome data
Two-hundred and ninety-six fetuses were randomised to immedi-
ate delivery, and 291 fetuses to deferred delivery.One woman with
a singleton pregnancy randomised to deferred delivery discharged
herself from hospital and was lost to follow-up. Early outcomes
of all other fetuses are reported (GRIT 2003), thus for early out-
comes there was less than 5% incomplete data and the risk of bias
is low.
At two-year assessment, an additional six babies in the immediate
delivery group and eight in the deferred group were lost to follow-
up (Thornton 2004), thus for two-year outcomes there was less
than 5% incomplete data and the risk of bias is low.
Childhood follow-up was attempted in children born to women
randomised in five of the original recruiting countries (Germany,
Italy, The Netherlands, Slovenia, and United Kingdom; Walker
2011). Data from Italy were not reported due to a high loss to fol-
low-up rate (75%). Follow-up data on children from other coun-
tries were available in 153/173 cases in the immediate delivery
group and 149/ 183 in the deferred delivery group. As there is
more than 5% incomplete data the risk of bias for childhood out-
comes is high.
Selective reporting
The study protocol was published online and available for review.
Outcomes and analysis strategies were prespecified, and there is
no evidence of selective reporting of outcomes.
Other potential sources of bias
Multiple pregnancies were included, but no adjustment was made
in the analysis to take account of non-independence between ba-
bies from the same pregnancy (Brocklehurst 2004).
Effects of interventions
Primary outcomes
There was no difference in perinatal mortality with immediate
delivery compared to deferred delivery (risk ratio (RR) 1.17, 95%
confidence interval (CI) 0.67 to 2.04, one trial, 587 participants
(Analysis 1.1)). There was also no difference in risk of the compos-
ite outcome of death or disability at or after two years (RR 1.22,
95% CI 0.85 to 1.75, one trial, 573 participants (Analysis 1.2)).
We were not able to calculate composite rates of severe neonatal
morbidity, even though individual morbidities were reported, due
to the risk of double counting infants with more than one mor-
bidity.
Secondary outcomes
There was a trend for decreased stillbirth with immediate delivery
(RR 0.22, 95% CI 0.05 to 1.00, one trial, 587 participants (
Analysis 1.3)). However, this was offset by a trend for increased
neonatal mortality (RR 1.84, 95% CI 0.93 to 3.62, one trial,
576 participants (Analysis 1.4)). There were no differences in post
neonatal mortality (RR 0.66, 95% CI 0.19 to 2.33, one trial, 541
participants (Analysis 1.5)) with immediate delivery compared to
deferred delivery.
There were no differences between the immediate delivery and
deferred delivery groups in any neonatal morbidity or marker of
neonatal morbidity prespecified in the protocol. Data were avail-
able on cord pH less than 7.00 (RR 0.50, 95% CI 0.09 to 2.70,
one trial, 400 participants (Analysis 1.7)); Apgar less than seven at
fiveminutes (RR 1.49, 95%CI 0.82 to 2.70, one trial, 560 partici-
pants (Analysis 1.8)); convulsions (RR 1.44, 95%CI 0.24 to 8.55,
one trial, 576 participants (Analysis 1.10)); IVH or GMH (RR
1.28, 95% CI 0.84 to 1.95, one trial, 576 participants (Analysis
1.11)); necrotising enterocolitis (RR 1.44, 95% CI 0.71 to 2.93,
one trial, 576 participants (Analysis 1.12)); and PVL or ventricu-
lomegaly (RR 2.04, 95% CI 0.89 to 4.65, one trial, 576 partici-
pants (Analysis 1.13)).
More children in the immediate delivery group had cerebral palsy
at or after two years of age (RR 5.88, 95% CI 1.33 to 26.02,
one trial, 507 participants (Analysis 1.15)). There was, however,
no difference in neurodevelopment impairment at or after two
years (RR 1.72, 95% CI 0.86 to 3.41, one trial, 507 participants
(Analysis 1.14)).
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Non-prespecified outcomes
More babies in the immediate delivery group were ventilated for
more than 24 hours (RR 1.54, 95%CI 1.20 to 1.97, one trial, 576
participants (Analysis 1.9)). There were no differences between
the immediate delivery and deferred delivery groups in death at
or after two years (RR 1.04, 95% CI 0.66 to 1.63, one trial, 573
participants (Analysis 1.6)); death or disability in childhood (six
to 13 years of age) (RR 0.82, 95% CI 0.48 to 1.40, one trial,
302 participants (Analysis 1.16)); or mean difference (MD) in
childhood Kaufman-ABCMPC Score (MD -1.00, 95% CI -4.47
to 2.47, one trial, 269 participants (Analysis 1.17)).
Subgroup analysis
Compared to deferred delivery, the RR of death or disability at two
years with immediate delivery was 1.21 (95% CI 0.81 to 1.80) at
24 to 30 weeks (subgroup A), and 1.04 (95% CI 0.54 to 2.01) at
31 to 36 weeks (subgroup B). No significant difference in effect
was found between the subgroups (P = 0.70) (see Analysis 1.19).
Maternal outcomes
More women in the immediate delivery group had caesarean de-
livery than in the deferred delivery group (RR 1.15, 95% CI 1.07
to 1.24, one trial, 547 participants (Analysis 1.18)). Data were not
available on any other maternal outcomes.
D I S C U S S I O N
Summary of main results
We identified one study (involving 548 women (588 babies)) ex-
amining whether immediate or deferred delivery improved out-
comes when there is suspected fetal compromise in the preterm fe-
tus. This study only included cases of suspected fetal compromise
where there was uncertainty whether immediate delivery was indi-
cated, thus results must be interpreted with caution. The available
data showed immediate delivery results in higher rates of caesarean
delivery than deferred delivery. Although no differences were ev-
ident in perinatal mortality or a composite measure of mortal-
ity and significant morbidity at two years, immediate delivery re-
sulted in more neonatal ventilation and more cerebral palsy at two
years of age. Childhood outcomes have also been reported, and
although it must be noted that follow-up data were incomplete,
no differences in outcome were found between immediate and de-
ferred delivery groups. Together these findings suggest that where
there is uncertainty whether or not to deliver a preterm fetus with
suspected fetal compromise, there is no benefit to immediate de-
livery. Deferring delivery until test results worsen or increasing
gestation favours delivery, may improve outcome for mother and
neonate.
Overall completeness and applicability of
evidence
There is a lack of trials in this area, and only one study was identi-
fied. Although it is a relatively large study, it has insufficient power
to detect differences in neonatal mortality. It did not report any
maternal outcomes, other than mode of delivery, or evaluate ma-
ternal satisfaction or economic outcomes.
The applicability of the findings is limited by several factors. Firstly,
the broad inclusion criteria of the included trial, which recruited
women with a range of different Doppler findings and obstetric
complications, as well as different gestational ages. Numbers were
insufficient to allow meaningful assessment of the impact of the
severity of Doppler abnormality or the presence of obstetric condi-
tions (for example, maternal hypertension or vaginal bleeding) on
outcomes. The potential benefits of immediate delivery are likely
to change with gestation. Post hoc subgroup analysis did not detect
any significant difference in the effect of immediate or deferred
delivery at early (24 to 30 weeks) or later (31 to 36 weeks) gesta-
tions, although there was a trend for an increased relative risk of
death and disability at two years in the earlier gestation subgroup.
Secondly, the study only included cases where the responsible clin-
ician was uncertain whether to deliver or not. The authors were
unable to report how many eligible women were offered partici-
pation, how many declined randomisation or how many poten-
tial participants were not included because of clinician certainty
regarding timing for delivery. Thus, the proportion of pregnant
women with suspected fetal compromise included in the study,
and the generalisability of the findings, are unclear.
Thirdly, the difference in themedian time between randomisation
and delivery in the two groups was four days. The potential ben-
efits of deferring delivery for longer or shorter periods cannot be
presumed.
Finally, the study did not evaluate the use of more recently de-
veloped Doppler assessment techniques such as ductus venosus
or middle cerebral artery waveforms which may diagnose more
accurately severe compromise and help make decisions about the
timing of delivery (Alfirevic 2010).
Quality of the evidence
We identified a single study, which was a large study of good
quality, performed in 13 countries. The nature of the interven-
tion means that participants could be blinded to treatment group.
However, the assessors were blinded to allocation at two-year as-
sessment.
The design and analysis of the included study was Bayesian. This
differs from conventional methodology, where differences in out-
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come are assessed with P values. Instead odds ratios were presented
with credibility indices (similar to confidence intervals, represent-
ing the range in which the true value is likely to lie) and these
were used to revise hypothetical prior beliefs that clinicians may
have had regarding the benefits of immediate or deferred delivery.
A purported advantage of this design is to allow assessment of the
impact that the trial findings will have on clinical practice. Integral
to the design is the presentation of unmasked data to collabora-
tors as well as the data monitoring committee, in order to allow
collaborators to modify their beliefs on the benefit or harm of the
intervention. Although this differs from traditional methodology
where interim analysis and findings are masked, we do not believe
it was an important bias.
Despite the robustness of the study design of the included trial,
the lack of other studies and limited applicability of the findings
mean caution must be used in the interpretation of the findings.
Potential biases in the review process
We specified broad inclusion criteria for this review, sowe could use
all the available evidence. However, only one study was identified
despite a rigorous literature search, meaning analysis was limited.
Agreements and disagreements with other
studies or reviews
We are not aware of any other studies or reviews investigating
this question. The results of the Truffle Study are awaited (Proto-
col 02PRT/34 Trial of umbilical and fetal flow in Europe (TRUF-
FLE): a multicentre randomised study), which aims to investigate
whichmethod of assessment (venousDoppler or cardiotocograph)
should be used to determine timing of delivery of the preterm
fetus with suspected fetal compromise.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Currently there is insufficient evidence on the benefits and harms
of immediate delivery compared with deferred delivery in cases
of suspected fetal compromise at preterm gestations to make firm
recommendations to guide clinical practice. However, immediate
delivery appears to increase caesarean delivery and does not im-
prove neonatal outcome. When there is uncertainty regarding the
optimal time for delivery of the preterm fetus with suspected fetal
compromise, deferring delivery until test results worsen or increas-
ing gestation favours delivery, may improve outcome for mother
and neonate.
Implications for research
Further randomised trials are required.These should be adequately
powered to detect differences in maternal and neonatal morbidity
and mortality. Such studies should include economic evaluation
and investigation of maternal preferences.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Thornton 2004
Methods Randomised controlled trial.
Participants 548 women (singleton 509, multiple 39) 588 babies, 24-36 weeks’ gestation with um-
bilical artery Doppler recorded and uncertainty whether to deliver or not
Outcomes available at or after 2 years for 575 babies.
Interventions Immediate delivery (allowing 48 hours for completion of steroids)
OR
deferred delivery (when safe delivery could be delayed no longer, because worsening test
results or the passage of time favoured delivery)
Outcomes Death or disability (cerebral palsy, little or no vision, requirement for a hearing aid, or a
Griffiths DQ of 70 or less) at or after 2 years of age
Notes Primary outcome of GRIT trial.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random sequence.
Allocation concealment (selection bias) Low risk Allocation by an independent programmer.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded due to nature of intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors blinded to allocation at 2 year follow-up. It
is unclear whether assessors were blinded to allocation
at childhood follow-up therefore unclear risk of bias for
these outcomes
Incomplete outcome data (attrition bias)
All outcomes
Low risk Less than 5% incomplete data for early and 2 year out-
comes. More than 5% missing data for childhood out-
comes, therefore high risk of bias for these outcomes
Selective reporting (reporting bias) Low risk Protocol published and no suggestion of selective report-
ing of outcomes
Other bias High risk Trial did not account for non-independence of data in
relation to twin pregnancies
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Langenveld 2011 Protocol for ongoing trial (anticipated to complete in 2013) investigating immediate or deferred delivery for
maternal indications (gestational hypertension, chronic hypertension or pre-eclampsia)
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D A T A A N D A N A L Y S E S
Comparison 1. Immediate delivery versus deferred delivery




participants Statistical method Effect size
1 Extended perinatal mortality 1 587 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.67, 2.04]
2 Death or disability at or after 2
years
1 573 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.85, 1.75]
3 Stillbirth 1 587 Risk Ratio (M-H, Fixed, 95% CI) 0.22 [0.05, 1.00]
4 Neonatal mortality 1 576 Risk Ratio (M-H, Fixed, 95% CI) 1.84 [0.93, 3.62]
5 Postneonatal mortality (> 28
days to discharge)
1 541 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.19, 2.33]
6 Death at or after 2 years age 1 573 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.66, 1.63]
7 Cord pH less than 7.0 1 400 Risk Ratio (M-H, Fixed, 95% CI) 0.5 [0.09, 2.70]
8 Apgar less than 7 at 5 minutes 1 560 Risk Ratio (M-H, Fixed, 95% CI) 1.49 [0.82, 2.70]
9 Ventilation > 24 hours 1 576 Risk Ratio (M-H, Fixed, 95% CI) 1.54 [1.20, 1.97]
10 Convulsions 1 576 Risk Ratio (M-H, Fixed, 95% CI) 1.44 [0.24, 8.55]
11 Interventricular haemorrhage or
germinal matrix haemorrhage
1 576 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.84, 1.95]
12 Necrotising enterocolitis 1 576 Risk Ratio (M-H, Fixed, 95% CI) 1.44 [0.71, 2.93]
13 Periventricular leucomalacia or
ventriculomegaly
1 576 Risk Ratio (M-H, Fixed, 95% CI) 2.04 [0.89, 4.65]
14 Neurodevelopmental
impairment at or after 2 years
1 507 Risk Ratio (M-H, Fixed, 95% CI) 1.72 [0.86, 3.41]
15 Cerebral palsy at or after 2 years
of age
1 507 Risk Ratio (M-H, Fixed, 95% CI) 5.88 [1.33, 26.02]
16 Death of severe disability 6-13
years
1 302 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.48, 1.40]
17 Kaufman-ABC MPC 1 269 Mean Difference (IV, Fixed, 95% CI) -1.0 [-4.47, 2.47]
18 Caesarean delivery 1 547 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [1.07, 1.24]
19 Subgroup analysis: death or
disability at or after 2 years of
age
1 573 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.82, 1.62]
19.1 24-30 weeks gestation 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [0.81, 1.80]
19.2 31-36 weeks 1 373 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.54, 2.01]
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Analysis 1.1. Comparison 1 Immediate delivery versus deferred delivery, Outcome 1 Extended perinatal
mortality.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 1 Extended perinatal mortality
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 25/296 21/291 100.0 % 1.17 [ 0.67, 2.04 ]
Total (95% CI) 296 291 100.0 % 1.17 [ 0.67, 2.04 ]
Total events: 25 (Immediate delivery), 21 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours immediate del Favours deferred del
Analysis 1.2. Comparison 1 Immediate delivery versus deferred delivery, Outcome 2 Death or disability at
or after 2 years.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 2 Death or disability at or after 2 years
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 55/290 44/283 100.0 % 1.22 [ 0.85, 1.75 ]
Total (95% CI) 290 283 100.0 % 1.22 [ 0.85, 1.75 ]
Total events: 55 (Immediate delivery), 44 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.08 (P = 0.28)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
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Analysis 1.3. Comparison 1 Immediate delivery versus deferred delivery, Outcome 3 Stillbirth.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 3 Stillbirth
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 2/296 9/291 100.0 % 0.22 [ 0.05, 1.00 ]
Total (95% CI) 296 291 100.0 % 0.22 [ 0.05, 1.00 ]
Total events: 2 (Immediate delivery), 9 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.96 (P = 0.050)
Test for subgroup differences: Not applicable
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Favours immediate del Favours deferred del
Analysis 1.4. Comparison 1 Immediate delivery versus deferred delivery, Outcome 4 Neonatal mortality.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 4 Neonatal mortality
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 23/294 12/282 100.0 % 1.84 [ 0.93, 3.62 ]
Total (95% CI) 294 282 100.0 % 1.84 [ 0.93, 3.62 ]
Total events: 23 (Immediate delivery), 12 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.76 (P = 0.079)
Test for subgroup differences: Not applicable
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Favours immediate del Favours deferred del
18Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.5. Comparison 1 Immediate delivery versus deferred delivery, Outcome 5 Postneonatal
mortality (> 28 days to discharge).
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 5 Postneonatal mortality (> 28 days to discharge)
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 4/271 6/270 100.0 % 0.66 [ 0.19, 2.33 ]
Total (95% CI) 271 270 100.0 % 0.66 [ 0.19, 2.33 ]
Total events: 4 (Immediate delivery), 6 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Immediate delivery versus deferred delivery, Outcome 6 Death at or after 2
years age.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 6 Death at or after 2 years age
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 34/290 32/283 100.0 % 1.04 [ 0.66, 1.63 ]
Total (95% CI) 290 283 100.0 % 1.04 [ 0.66, 1.63 ]
Total events: 34 (Immediate delivery), 32 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.16 (P = 0.88)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Immediate delivery versus deferred delivery, Outcome 7 Cord pH less than 7.0.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 7 Cord pH less than 7.0
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 2/200 4/200 100.0 % 0.50 [ 0.09, 2.70 ]
Total (95% CI) 200 200 100.0 % 0.50 [ 0.09, 2.70 ]
Total events: 2 (Immediate delivery), 4 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
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Favours immediate del Favours deferred del
Analysis 1.8. Comparison 1 Immediate delivery versus deferred delivery, Outcome 8 Apgar less than 7 at 5
minutes.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 8 Apgar less than 7 at 5 minutes
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 25/278 17/282 100.0 % 1.49 [ 0.82, 2.70 ]
Total (95% CI) 278 282 100.0 % 1.49 [ 0.82, 2.70 ]
Total events: 25 (Immediate delivery), 17 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Immediate delivery versus deferred delivery, Outcome 9 Ventilation > 24 hours.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 9 Ventilation > 24 hours
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 114/294 71/282 100.0 % 1.54 [ 1.20, 1.97 ]
Total (95% CI) 294 282 100.0 % 1.54 [ 1.20, 1.97 ]
Total events: 114 (Immediate delivery), 71 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 3.42 (P = 0.00062)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Immediate delivery versus deferred delivery, Outcome 10 Convulsions.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 10 Convulsions
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 3/294 2/282 100.0 % 1.44 [ 0.24, 8.55 ]
Total (95% CI) 294 282 100.0 % 1.44 [ 0.24, 8.55 ]
Total events: 3 (Immediate delivery), 2 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Immediate delivery versus deferred delivery, Outcome 11 Interventricular
haemorrhage or germinal matrix haemorrhage.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 11 Interventricular haemorrhage or germinal matrix haemorrhage
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 44/294 33/282 100.0 % 1.28 [ 0.84, 1.95 ]
Total (95% CI) 294 282 100.0 % 1.28 [ 0.84, 1.95 ]
Total events: 44 (Immediate delivery), 33 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.15 (P = 0.25)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Immediate delivery versus deferred delivery, Outcome 12 Necrotising
enterocolitis.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 12 Necrotising enterocolitis
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 18/294 12/282 100.0 % 1.44 [ 0.71, 2.93 ]
Total (95% CI) 294 282 100.0 % 1.44 [ 0.71, 2.93 ]
Total events: 18 (Immediate delivery), 12 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Immediate delivery versus deferred delivery, Outcome 13 Periventricular
leucomalacia or ventriculomegaly.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 13 Periventricular leucomalacia or ventriculomegaly
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 17/294 8/282 100.0 % 2.04 [ 0.89, 4.65 ]
Total (95% CI) 294 282 100.0 % 2.04 [ 0.89, 4.65 ]
Total events: 17 (Immediate delivery), 8 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.69 (P = 0.090)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Immediate delivery versus deferred delivery, Outcome 14
Neurodevelopmental impairment at or after 2 years.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 14 Neurodevelopmental impairment at or after 2 years
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 21/256 12/251 100.0 % 1.72 [ 0.86, 3.41 ]
Total (95% CI) 256 251 100.0 % 1.72 [ 0.86, 3.41 ]
Total events: 21 (Immediate delivery), 12 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.54 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Immediate delivery versus deferred delivery, Outcome 15 Cerebral palsy at or
after 2 years of age.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 15 Cerebral palsy at or after 2 years of age
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 12/256 2/251 100.0 % 5.88 [ 1.33, 26.02 ]
Total (95% CI) 256 251 100.0 % 5.88 [ 1.33, 26.02 ]
Total events: 12 (Immediate delivery), 2 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 2.34 (P = 0.019)
Test for subgroup differences: Not applicable
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Analysis 1.16. Comparison 1 Immediate delivery versus deferred delivery, Outcome 16 Death of severe
disability 6-13 years.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 16 Death of severe disability 6-13 years
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 21/153 25/149 100.0 % 0.82 [ 0.48, 1.40 ]
Total (95% CI) 153 149 100.0 % 0.82 [ 0.48, 1.40 ]
Total events: 21 (Immediate delivery), 25 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.74 (P = 0.46)
Test for subgroup differences: Not applicable
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Analysis 1.17. Comparison 1 Immediate delivery versus deferred delivery, Outcome 17 Kaufman-ABCMPC.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 17 Kaufman-ABC MPC





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Thornton 2004 139 95 (15) 130 96 (14) 100.0 % -1.00 [ -4.47, 2.47 ]
Total (95% CI) 139 130 100.0 % -1.00 [ -4.47, 2.47 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours immediate del Favours deferred del
Analysis 1.18. Comparison 1 Immediate delivery versus deferred delivery, Outcome 18 Caesarean delivery.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 18 Caesarean delivery
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Thornton 2004 249/273 217/274 100.0 % 1.15 [ 1.07, 1.24 ]
Total (95% CI) 273 274 100.0 % 1.15 [ 1.07, 1.24 ]
Total events: 249 (Immediate delivery), 217 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 3.90 (P = 0.000097)
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 Immediate delivery versus deferred delivery, Outcome 19 Subgroup analysis:
death or disability at or after 2 years of age.
Review: Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Comparison: 1 Immediate delivery versus deferred delivery
Outcome: 19 Subgroup analysis: death or disability at or after 2 years of age
Study or subgroup Immediate delivery Deferred delivery Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 24-30 weeks gestation
Thornton 2004 39/107 28/93 65.6 % 1.21 [ 0.81, 1.80 ]
Subtotal (95% CI) 107 93 65.6 % 1.21 [ 0.81, 1.80 ]
Total events: 39 (Immediate delivery), 28 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.94 (P = 0.35)
2 31-36 weeks
Thornton 2004 16/183 16/190 34.4 % 1.04 [ 0.54, 2.01 ]
Subtotal (95% CI) 183 190 34.4 % 1.04 [ 0.54, 2.01 ]
Total events: 16 (Immediate delivery), 16 (Deferred delivery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
Total (95% CI) 290 283 100.0 % 1.15 [ 0.82, 1.62 ]
Total events: 55 (Immediate delivery), 44 (Deferred delivery)
Heterogeneity: Chi2 = 0.15, df = 1 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Chi2 = 0.15, df = 1 (P = 0.70), I2 =0.0%
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The Methods section has been updated.
The definition of the primary outcome perinatal mortality (intrauterine death or death in the first seven days of life) was amended
to represent extended perinatal mortality (intrauterine death or death in the first 28 days of life), as deaths in the neonatal period are
frequently secondary to obstetric causes, and these were felt to be relevant.
We also reported the following non-prespecified outcomes that we considered to be important: death at or after two years of age;
Kaufman-Assessment Battery for Children Mental Processing Component Score in childhood; death or severe disability in childhood;
ventilation for more than 24 hours.
We had intended to perform subgroup analyses for gestations less than 28 weeks, 28 to 31+6 weeks and 32 to 36 weeks. Data were
not available for the groups specified but were available for gestations 24 to 30 weeks and gestations 31 to 36 weeks. As the effect of
gestation could be important, we performed post hoc subgroup analysis for these groups.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Fetal Distress [complications]; ∗Infant, Premature; Cerebral Palsy [etiology]; Cesarean Section [utilization];Delivery,Obstetric [adverse
effects; ∗methods]; Infant Mortality; Infant, Newborn; Randomized Controlled Trials as Topic; Respiration, Artificial [utilization];
Watchful Waiting
MeSH check words
Female; Humans; Infant; Pregnancy
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